Tick-Borne Relapsing Fever (TBRF) Managed Properly
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Blood Smear Analysis in Babesiosis, Ehrlichiosis, Relapsing Fever, Malaria, and Chagas Disease
REVIEW STEVE M. BLEVINS, MD RONALD A. GREENFIELD, MD* MICHAEL S. BRONZE, MD CME Assistant Professor of Medicine, Section Professor of Medicine, Section of Infectious Professor of Medicine, Section of Infectious CREDIT of General Internal Medicine, Department Diseases, Department of Medicine, University Diseases, Chair of Department of Medicine, of Medicine, University of Oklahoma of Oklahoma Health Sciences Center and the University of Oklahoma Health Sciences Center Health Sciences Center, Oklahoma City Oklahoma City Veterans Administration and the Oklahoma City Veterans Administration Medical Center Medical Center Blood smear analysis in babesiosis, ehrlichiosis, relapsing fever, malaria, and Chagas disease ■ ABSTRACT LOOD SMEAR ANALYSIS, while commonly B used to evaluate hematologic condi- Blood smear analysis is especially useful for diagnosing tions, is infrequently used to diagnose infec- five infectious diseases: babesiosis, ehrlichiosis, relapsing tious diseases. This is because of the rarity of fever due to Borrelia infection, malaria, and American diseases for which blood smear analysis is indi- trypanosomiasis (Chagas disease). It should be performed cated. Consequently, such testing is often in patients with persistent or recurring fever or in those overlooked when it is diagnostically impor- who have traveled to the developing world or who have tant. a history of tick exposure, especially if accompanied by Nonspecific changes may include mor- hemolytic anemia, thrombocytopenia, or phologic changes in leukocytes and erythro- 1 hepatosplenomegaly. cytes (eg, toxic granulations, macrocytosis). And with certain pathogens, identifying ■ KEY POINTS organisms in a peripheral blood smear allows for a rapid diagnosis. In the United States, malaria and American This paper discusses the epidemiology, trypanosomiasis principally affect travelers from the clinical manifestations, laboratory findings, developing world. -
Transmission and Evolution of Tick-Borne Viruses
Available online at www.sciencedirect.com ScienceDirect Transmission and evolution of tick-borne viruses Doug E Brackney and Philip M Armstrong Ticks transmit a diverse array of viruses such as tick-borne Bourbon viruses in the U.S. [6,7]. These trends are driven encephalitis virus, Powassan virus, and Crimean-Congo by the proliferation of ticks in many regions of the world hemorrhagic fever virus that are reemerging in many parts of and by human encroachment into tick-infested habitats. the world. Most tick-borne viruses (TBVs) are RNA viruses that In addition, most TBVs are RNA viruses that mutate replicate using error-prone polymerases and produce faster than DNA-based organisms and replicate to high genetically diverse viral populations that facilitate their rapid population sizes within individual hosts to form a hetero- evolution and adaptation to novel environments. This article geneous population of closely related viral variants reviews the mechanisms of virus transmission by tick vectors, termed a mutant swarm or quasispecies [8]. This popula- the molecular evolution of TBVs circulating in nature, and the tion structure allows RNA viruses to rapidly evolve and processes shaping viral diversity within hosts to better adapt into new ecological niches, and to develop new understand how these viruses may become public health biological properties that can lead to changes in disease threats. In addition, remaining questions and future directions patterns and virulence [9]. The purpose of this paper is to for research are discussed. review the mechanisms of virus transmission among Address vector ticks and vertebrate hosts and to examine the Department of Environmental Sciences, Center for Vector Biology & diversity and molecular evolution of TBVs circulating Zoonotic Diseases, The Connecticut Agricultural Experiment Station, in nature. -
Borrelia Burgdorferi and Treponema Pallidum: a Comparison of Functional Genomics, Environmental Adaptations, and Pathogenic Mechanisms
PERSPECTIVE SERIES Bacterial polymorphisms Martin J. Blaser and James M. Musser, Series Editors Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms Stephen F. Porcella and Tom G. Schwan Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, Montana, USA Address correspondence to: Tom G. Schwan, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, Montana 59840, USA. Phone: (406) 363-9250; Fax: (406) 363-9445; E-mail: [email protected]. Spirochetes are a diverse group of bacteria found in (6–8). Here, we compare the biology and genomes of soil, deep in marine sediments, commensal in the gut these two spirochetal pathogens with reference to their of termites and other arthropods, or obligate parasites different host associations and modes of transmission. of vertebrates. Two pathogenic spirochetes that are the focus of this perspective are Borrelia burgdorferi sensu Genomic structure lato, a causative agent of Lyme disease, and Treponema A striking difference between B. burgdorferi and T. pal- pallidum subspecies pallidum, the agent of venereal lidum is their total genomic structure. Although both syphilis. Although these organisms are bound togeth- pathogens have small genomes, compared with many er by ancient ancestry and similar morphology (Figure well known bacteria such as Escherichia coli and Mycobac- 1), as well as by the protean nature of the infections terium tuberculosis, the genomic structure of B. burgdorferi they cause, many differences exist in their life cycles, environmental adaptations, and impact on human health and behavior. The specific mechanisms con- tributing to multisystem disease and persistent, long- term infections caused by both organisms in spite of significant immune responses are not yet understood. -
Tick-Borne Relapsing Fever CLAY ROSCOE, M.D., and TED EPPERLY, M.D., Family Medicine Residency of Idaho, Boise, Idaho
Tick-Borne Relapsing Fever CLAY ROSCOE, M.D., and TED EPPERLY, M.D., Family Medicine Residency of Idaho, Boise, Idaho Tick-borne relapsing fever is characterized by recurring fevers separated by afebrile periods and is accompanied by nonspecific constitutional symptoms. It occurs after a patient has been bitten by a tick infected with a Borrelia spirochete. The diagnosis of tick-borne relapsing fever requires an accurate characterization of the fever and a thorough medical, social, and travel history of the patient. Findings on physical examination are variable; abdominal pain, vomiting, and altered sensorium are the most common symptoms. Laboratory confirmation of tick-borne relapsing fever is made by detection of spirochetes in thin or thick blood smears obtained during a febrile episode. Treatment with a tetracycline or macrolide antibiotic is effective, and antibiotic resistance is rare. Patients treated for tick-borne relapsing fever should be monitored closely for Jarisch- Herxheimer reactions. Fatalities from tick-borne relapsing fever are rare in treated patients, as are subsequent Jarisch-Herxheimer reactions. Persons in endemic regions should avoid rodent- and tick-infested areas and use insect repellents and protective clothing to prevent tick bites. (Am Fam Physician 2005;72:2039-44, 2046. Copyright © 2005 American Academy of Family Physicians.) S Patient information: ick-borne relapsing fever (TBRF) develop with TBRF, with long-term sequelae A handout on tick-borne is transmitted by Ornithodoros that may be permanent. Reviewing a broad relapsing fever, written by 1,3-6 the authors of this article, ticks infected with one of sev- differential diagnosis (Table 1 ) for fever is provided on page 2046. -
Lyme Disease and Tick-Borne Infections User Manual
SCOTTISH MICROBIOLOGY REFERENCE LABORATORY, INVERNESS: LYME DISEASE AND TICK-BORNE INFECTIONS USER MANUAL 1 Amended 23 September 2020 CONTENTS Section Page 1 Introduction 3 2 Contact details and key personnel 3 3 Opening hours 4 4 Service provided 4 4.1 Samples and turnaround times 4 4.2 Laboratory tests 5 4.3 Specialist advice 5 5 Clinical Information 6 6 Referral criteria 6 7 Specimen and request form labelling 7 8 Specimen transportation 8 9 Charges 8 10 Results 8 11 Treatment 8 12 Prevention 8 13 SLDTRL request form 8 (Form MF023) 14 SLDTRL developments 9 15 References 9 16 Laboratory diagnosis of Lyme borreliosis algorithm Appendix 2 Amended 23 September 2020 1.0 Introduction The newly established Scottish Lyme Disease and Tick-borne Infections Reference Laboratory (SLDTRL) is provided by NHS Highland at Raigmore Hospital, Inverness. The aim of SLDTRL is to provide more comprehensive and standardised testing for Lyme disease and other tick-borne infections and to improve the epidemiological data provided to Health Protection Scotland (HPS). Lyme disease is caused by bacteria from the Borrelia burgdorferi sensu lato complex. In the UK the bacteria is transmitted to humans through the bite of infected, hard bodied, Ixodes ricinus ticks. Borrelia miyamotoi disease, which presents as a relapsing fever, can also be transmitted by Ixodes ricinus ticks. It is an emerging disease caused by B. miyamotoi bacteria, which are from the relapsing fever group of borrelia, genetically distinct from those that cause Lyme disease. Human granulocytic anaplasmosis (HGA), also an acute febrile illness transmitted by Ixodid ticks, is an infection caused by the bacterium Anaplasma phagocytophilum. -
The Relapsing Fever Agent Borrelia Hermsii Has Multiple
Copyright Q 1992 by the Genetics Societyof America The Relapsing Fever AgentBorrelia hermsii Has Multiple Copiesof Its Chromosome and Linear Plasmids Todd Kitten and Alan G. Barbour Departments of Microbiology and Medicine, The Universityof Texas Health Science Center, Sun Antonio, Texas 78284 Manuscript received March 17, 1992 Accepted for publicationJune 25, 1992 ABSTRACT Borrelia hermsii, a spirochete which causes relapsing fever in humans and other mammals, eludes the immune responseby antigenic variationof the “Vmp” proteins.This occurs by replacement of an expressed vrnp gene with a copy of a silent vrnp gene. Silent and expressedvrnp genes are located on separate linearplasmids. To further characterize vrnp recombination, copy numbers were determined for two linear plasmids and for the l-megabase chromosome by comparing hybridization of probes to native DNA with hybridization to recombinant plasmids containing borrelial DNA. Plasmid copy numbers were also estimated by ethidium bromide fluorescence. Total cellular DNA content was determined by spectrophotometry. For borreliasgrown in mice, copy numbers and 95% confidence intervals were 14 (12-17)for an expression plasmid,8 (7-9) for a silent plasmid, and 16 (13-18) for the chromosome. Borrelias grown in broth mediumhad one-fourth to one-half this number of plasmids and chromosomes. Staining of cells with4’,6-diamidino-2-phenylindole revealed DNA to be distributed throughout most of the spirochete’s length. These findings indicate that borrelias organize their total cellular DNA into several complete genomes and thatcells undergoing serotype switches do one or more of the following: (1) coexpress Vmps from switched and unswitched expression plasmids for at least three to five generations, (2)suppress transcription from some expressionplasmid copies, or (3) partition expression plasmids nonrandomly.The lower copy number ofthe silentplasmid indicates that nonreciprocal Vmp gene recombination may result from loss of recombinant silent ” plasmids by segregation. -
Fluralaner Activity Against Life Stages of Ticks Using Rhipicephalus
Williams et al. Parasites & Vectors (2015) 8:90 DOI 10.1186/s13071-015-0704-x RESEARCH Open Access Fluralaner activity against life stages of ticks using Rhipicephalus sanguineus and Ornithodoros moubata IN in vitro contact and feeding assays Heike Williams*, Hartmut Zoller, Rainer KA Roepke, Eva Zschiesche and Anja R Heckeroth Abstract Background: Fluralaner is a novel isoxazoline eliciting both acaricidal and insecticidal activity through potent blockage of GABA- and glutamate-gated chloride channels. The aim of the study was to investigate the susceptibility of juvenile stages of common tick species exposed to fluralaner through either contact (Rhipicephalus sanguineus) or contact and feeding routes (Ornithodoros moubata). Methods: Fluralaner acaricidal activity through both contact and feeding exposure was measured in vitro using two separate testing protocols. Acaricidal contact activity against Rhipicephalus sanguineus life stages was assessed using three minute immersion in fluralaner concentrations between 50 and 0.05 μg/mL (larvae) or between 1000 and 0.2 μg/mL (nymphs and adults). Contact and feeding activity against Ornithodoros moubata nymphs was assessed using fluralaner concentrations between 1000 to 10−4 μg/mL (contact test) and 0.1 to 10−10 μg/mL (feeding test). Activity was assessed 48 hours after exposure and all tests included vehicle and untreated negative control groups. Results: Fluralaner lethal concentrations (LC50,LC90/95) were defined as concentrations with either 50%, 90% or 95% killing effect in the tested sample population. After contact exposure of R. sanguineus life stages lethal concentrations were (μg/mL): larvae - LC50 0.7, LC90 2.4; nymphs - LC50 1.4, LC90 2.6; and adults - LC50 278, LC90 1973. -
IS IT LYME DISEASE, Or TICK-BORNE RELAPSING FEVER?
IS IT LYME DISEASE, or TICK-BORNE RELAPSING FEVER? Webinar Presented by Joseph J. Burrascano Jr. M.D. Joined by Jyotsna Shah PhD for the Q&A January 2020 Presenters Joseph J. Burrascano Jr. M.D. • Well-known pioneer in the field of tick-borne diseases, active since 1985 • Founding member of ILADS and ILADEF • Active in physician education on all aspects of tick-borne diseases Jyotsna Shah, PhD • President & Laboratory Director of IGeneX Clinical Laboratory • Over 40 Years of Research Experience in Immunology, Molecular Biology & Microbiology • Author of Multiple Publications & Holds More Than 20 Patents • Member of ILRAD as a Post-Doctoral Scientist • Started the First DNA Sequencing Laboratory in E. Africa 2 Poll Question Before we begin, we’d like to ask a poll question. Which one of these Borrelia causes Tick-Borne Relapsing Fever (TBRF)? a) B. mayonii b) B. turicatae c) B. burgdorferi d) B. andersonii e) B. garinii 3 Poll Question Before we begin, we’d like to ask a poll question. Which one of these Borrelia causes Tick-Borne Relapsing Fever (TBRF)? a) B. mayonii - Lyme b) B. turicatae - TBRF c) B. burgdorferi - Lyme d) B. andersonii - Lyme e) B. garinii – Lyme strain in Europe 4 What is TBRF? • Has been defined by clinical presentation • Has been defined by tick vector • Has been defined by genetics • Has been defined by serotype BUT • Each of these has exceptions and limitations! 5 Clinical Presentation of Classic TBRF • “Recurring febrile episodes that last ~3 days and are separated by afebrile periods of ~7 days duration.” • “Each febrile episode involves a “crisis.” During the “chill phase” of the crisis, patients develop very high fever (up to 106.7°F) and may become delirious, agitated, tachycardic and tachypneic. -
Tick-Borne Disease Working Group 2020 Report to Congress
2nd Report Supported by the U.S. Department of Health and Human Services • Office of the Assistant Secretary for Health Tick-Borne Disease Working Group 2020 Report to Congress Information and opinions in this report do not necessarily reflect the opinions of each member of the Working Group, the U.S. Department of Health and Human Services, or any other component of the Federal government. Table of Contents Executive Summary . .1 Chapter 4: Clinical Manifestations, Appendices . 114 Diagnosis, and Diagnostics . 28 Chapter 1: Background . 4 Appendix A. Tick-Borne Disease Congressional Action ................. 8 Chapter 5: Causes, Pathogenesis, Working Group .....................114 and Pathophysiology . 44 The Tick-Borne Disease Working Group . 8 Appendix B. Tick-Borne Disease Working Chapter 6: Treatment . 51 Group Subcommittees ...............117 Second Report: Focus and Structure . 8 Chapter 7: Clinician and Public Appendix C. Acronyms and Abbreviations 126 Chapter 2: Methods of the Education, Patient Access Working Group . .10 to Care . 59 Appendix D. 21st Century Cures Act ...128 Topic Development Briefs ............ 10 Chapter 8: Epidemiology and Appendix E. Working Group Charter. .131 Surveillance . 84 Subcommittees ..................... 10 Chapter 9: Federal Inventory . 93 Appendix F. Federal Inventory Survey . 136 Federal Inventory ....................11 Chapter 10: Public Input . 98 Appendix G. References .............149 Minority Responses ................. 13 Chapter 11: Looking Forward . .103 Chapter 3: Tick Biology, Conclusion . 112 Ecology, and Control . .14 Contributions U.S. Department of Health and Human Services James J. Berger, MS, MT(ASCP), SBB B. Kaye Hayes, MPA Working Group Members David Hughes Walker, MD (Co-Chair) Adalbeto Pérez de León, DVM, MS, PhD Leigh Ann Soltysiak, MS (Co-Chair) Kevin R. -
Uvic Thesis Template
Investigating the Role of Pallilysin in the Dissemination of the Syphilis Spirochete Treponema pallidum by Yavor Denchev Bachelor of Science, University of Victoria, 2011 A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in the Department of Biochemistry and Microbiology Yavor Denchev, 2014 University of Victoria All rights reserved. This thesis may not be reproduced in whole or in part, by photocopy or other means, without the permission of the author. ii Supervisory Committee Investigating the Role of Pallilysin in the Dissemination of the Syphilis Spirochete Treponema pallidum by Yavor Denchev Bachelor of Science, University of Victoria, 2011 Supervisory Committee Dr. Caroline Cameron, Department of Biochemistry and Microbiology Supervisor Dr. Terry Pearson, Department of Biochemistry and Microbiology Departmental Member Dr. John Taylor, Department of Biology Outside Member iii Abstract Supervisory Committee Dr. Caroline Cameron, Department of Biochemistry and Microbiology Supervisor Dr. Terry Pearson, Department of Biochemistry and Microbiology Departmental Member Dr. John Taylor, Department of Biology Outside Member Syphilis is a global public health concern with 36.4 million cases worldwide and 11 million new infections per year. It is a chronic multistage disease caused by the spirochete bacterium Treponema pallidum and is transmitted by sexual contact, direct contact with lesions or vertically from an infected mother to her fetus. T. pallidum is a highly invasive pathogen that rapidly penetrates tight junctions of endothelial cells and disseminates rapidly via the bloodstream to establish widespread infection. Previous investigations conducted in our laboratory identified the surface-exposed adhesin, pallilysin, as a metalloprotease that degrades the host components laminin (major component of the basement membrane lining blood vessels) and fibrinogen (primary component of the coagulation cascade), as well as fibrin clots (function to entrap bacteria and prevent disseminated infection). -
Colorado Ticks and Tick-Borne Diseases Fact Sheet No
Colorado Ticks and Tick-Borne Diseases Fact Sheet No. 5.593 Insect Series|Trees and Shrubs by W.S. Cranshaw, F.B. Peairs and B.C. Kondratieff* Ticks are blood-feeding parasites of Quick Facts animals found throughout Colorado. They are particularly common at higher elevations. • The most common tick that Problems related to blood loss do occur bites humans and dogs among wildlife and livestock, but they are in Colorado is the Rocky rare. Presently 27 species of ticks are known Mountain wood tick. to occur in Colorado and Table 1 lists the more common ones. Almost all human • Rocky Mountain wood tick is encounters with ticks in Colorado involve most active and does most the Rocky Mountain wood tick. Fortunately, biting in spring, becoming some of the most important tick species dormant with warm weather in present elsewhere in the United States are summer. Figure 1: Adult Rocky Mountain wood tick prior either rare (lone star tick) or completely to feeding. Rocky Mountain wood tick is the most • Colorado tick fever is by far absent from the state (blacklegged tick). common tick that is found on humans and pets in Ticks most affect humans by their ability Colorado. the most common tick- to transmit pathogens that produce several transmitted disease of the important diseases. Diseases spread by ticks region. Despite its name, in Colorado include Colorado tick fever, Rocky Mountain spotted fever Rocky Mountain spotted fever, tularemia and is quite rare here. relapsing fever. • Several repellents are recommended for ticks Life Cycle of Ticks including DEET, picaridin, Two families of ticks occur in Colorado, Figure 2: Adult female and male of the Rocky IR3535, and oil of lemon hard ticks (Ixodidae family) and soft ticks Mountain wood tick. -
Borrelia Species
APPENDIX 2 Borrelia Species Likelihood of Secondary Transmission: • Secondary transmission of relapsing fever from blood Disease Agent: exposure or blood contact with broken skin or con- • Borrelia recurrentis—Tick-borne relapsing fever junctiva, contaminated needles • B. duttoni—Louse-borne relapsing fever At-Risk Populations: Disease Agent Characteristics: • Persons with exposure to the tick vector and people living in crowded conditions with degraded public • Not classified as either Gram-positive or Gram- health infrastructure negative, facultatively intracellular bacterium • Order: Spirochaetales; Family: Spirochaetaceae Vector and Reservoir Involved: • Size: 20-30 ¥ 0.2-0.3 mm • Nucleic acid: Approximately 1250-1570 kb of DNA • Argasid (soft) ticks: Tick-borne (endemic) relapsing fever. Rodents are the reservoir. Disease Name: • Human body louse: Louse-borne (epidemic) relaps- ing fever. No nonhuman reservoir • Relapsing fever Blood Phase: Priority Level: • Bacteria are present in high numbers in the blood • Scientific/Epidemiologic evidence regarding blood during febrile episodes and at lower levels between safety: Very low fevers. • Public perception and/or regulatory concern regard- • The duration of bacteremia is not well characterized, ing blood safety: Absent but recurrent fevers can persist for several weeks to • Public concern regarding disease agent: Very low months. Background: Survival/Persistence in Blood Products: • Relapsing fevers occur throughout the world, with the • No information for B. recurrentis; however, laboratory exception of a few areas in the Southwest Pacific. The studies indicate that B. burgdorferi survives in fresh distribution and occurrence of endemic tick-borne frozen plasma, RBCs, and platelets for the duration of relapsing fever (TBRF) are governed by the presence their storage period.